Exporter Supply Landscape

Supplier countries for containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale

A reported trade view for HS 300443, with available observations through 2024.

HS6 300443Coverage 1995-2024Updated 2026-08-14
Explore this product

Leading supplier

Ireland$40.6M

Supplier countries

181Reported suppliers

Top supplier reach

4Destination markets

Latest global trade

$71.1MYear: 2024

Reported observations

Supplier evidence

Supplier countries ranked by latest reported export value.

SupplierLatest exports5-year growthDestinationsLeading destination
Ireland$40.6M+242.1%4Egypt
Denmark$7.1M+6.3%5Egypt
France$7.1M+15.2%34United Kingdom
Indonesia$4.6M-3.6%7Philippines
Germany$3.7M+8.2%9Egypt
Sweden$2.0M+21.8%3Norway
USA$2.0M+64.9%23Egypt
Estonia$1.7M+50.3%7Netherlands
Latvia$1.6M+126.4%4Estonia
Norway$1.6M+979.9%0Spain
Finland$1.4M+89.1%3Egypt
United Kingdom$1.2M+69.6%11Egypt
Philippines$1.1M-1.6%1South Africa
Canada$1.1M+296.5%2Egypt
Spain$1.1M+188.4%4Hungary
Czechia$1.1M-28.9%2Bulgaria
United Arab Emirates$861.6K-22.1%3Zimbabwe
Austria$828.4K-10.3%2Sweden
Singapore$787.5K+553.6%2Egypt
Italy$667.2K+10.4%7Egypt
Slovakia$652.8K+111.5%2Poland
Belgium$640.5K-21.5%6Denmark
Iran$554.7K-55.7%0Ukraine
Egypt$476.3K-25.6%1Ukraine
Saudi Arabia$474.8K-60.5%0Iraq
Bulgaria$427.7K-87.2%1Slovakia
Netherlands$412.3K+7.5%13Egypt
Greece$335.7K+36.9%2France
Panama$313.6K-76.2%0Dominican Republic
China$285.3K-7.3%4Bolivia
India$220.5K-13.3%17Panama
Romania$203.3K+6.5%2Estonia
Australia$199.1K+23.7%7Netherlands
World excl. EU$187.4K+192.3%2Malawi
Poland$174.1K-34.6%2Taiwan

Market reading

Which countries supply containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale?

Ireland is the leading reported supplier in this view, with exports of $40.6M.

How to use this view

Start with the leading rows in the first table, then use the chart to compare supplier scale and destination reach for containing alkaloids or their derivatives, containing norephedrine or its salts, for therapeutic or prophylactic uses, packaged for retail sale. The second table adds a related reported comparison.

Coverage extends to 2024. Missing values are shown as not reported.

Further comparison

Supplier corridor unit-value evidence

Reported corridor unit values for the selected supplier, compared with each buyer market's median.

Buyer marketReported yearTrade valueQuantityUnit value USD/tonBuyer-market median USD/ton
United Kingdom2023$11.5K0.3 t$37,645.9$39,810.53
United Kingdom2022$8.1K0.1 t$84,385.42$50,540
Estonia2022$1.6K0 t$107,533.33$107,533.33
Norway2022$1.4K0 t$235,666.67$320,000
Netherlands2022$33.00 t$33,000$36,000
United Kingdom2020$4.9K0 t$121,350$121,350
Poland2020$213.02.5 t$86.48$48,333.33
United Arab Emirates2020$105.00 t$105,000$105,000
Estonia2019$847.00 t$121,000$112,690.97
United Kingdom2019$180.00 t$60,000$60,000
Spain2017$1.1K1.6 t$706.69$53,668.16

Explore related views

Continue with another perspective on this product.

Latest observed year: 2024. Page updated 2026-08-14.

Source and date

Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.

Definitions

Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.

Reading the data

“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.